What is Inception?
Inception operates as a multifaceted investment vehicle, distinguishing itself through a hands-on operational philosophy. Unlike passive capital providers, the firm actively engages in corporate strategy and board-level oversight, ensuring that its holdings—ranging from real estate and consumer retail to vaporization technology—are optimized for long-term value creation. With an aggregated enterprise value exceeding $5 billion, the firm serves as a critical bridge between institutional capital and high-growth, specialized industries. Its portfolio, which includes notable entities such as Medmen, JUUL/Pax, and Weedmaps, highlights a strategic focus on sectors characterized by high barriers to entry and significant regulatory complexity.
How much funding has Inception raised?
Inception has raised a total of $15M across 1 funding round:
Series A
$15M
Series A (2017): $15M with participation from RTL Group and iAngels
Key Investors in Inception
RTL Group
RTL Group is a leading European media conglomerate specializing in broadcasting, content production, and digital media services with a vast international footprint.
iAngels
iAngels is a venture capital firm that provides investors with access to high-growth technology startups and early-stage investment opportunities.
What's next for Inception?
Looking ahead, Inception is poised to leverage its recent capital infusion to deepen its footprint in ancillary strategic data aggregation and consumer-facing platforms. As the legal cannabis market matures, the firm's emphasis on operational oversight and board representation will likely serve as a competitive advantage, allowing it to steer its portfolio companies through consolidation phases and market volatility. By maintaining its focus on high-growth, opportunistic assets, Inception is well-positioned to continue its expansion, potentially targeting further integration of its real estate and technology holdings to create a more cohesive, vertically integrated ecosystem.
See full Inception company page